Investegate |Avacta Group PLC Announcements | Avacta Group PLC: Block Listing Application to AIM
Investegate announcements from Avacta Group PLC, Block Listing Application to AIM
Source: investegate.co.uk
Page 12 - Zyme Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Zyme Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Zyme Communications Today - Breaking & Trending Today
CN Bio Introduces PhysioMimix NASH 'in-a-box' Reagent Kit
First product within new 'in-a-box' range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery CN Bio, a leading
Source: finanznachrichten.de
Investegate |Avacta Group PLC Announcements | Avacta Group PLC: Issue of Equity and Total Voting Rights
Investegate announcements from Avacta Group PLC, Issue of Equity and Total Voting Rights
Source: investegate.co.uk
Avacta Group plc: Avacta Announces AffyXell Joint Venture Milestone and Increased Equity Stake
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION platforms, is pleased to announce that a milestone
Source: finanznachrichten.de
Frost & Sullivan Hails Sphere Fluidics for Enabling Efficient, Faster, and More Cost-effective Single-cell Analysis with Its Microfluidic Platforms
/PRNewswire/ -- Frost & Sullivan recently analyzed the European microfluidic platforms for biological screening and discovery market and, based on its...
Source: prnewswire.com